194 related articles for article (PubMed ID: 28432296)
1. Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes.
Bolze F; Mocek S; Zimmermann A; Klingenspor M
Sci Rep; 2017 Apr; 7(1):1020. PubMed ID: 28432296
[TBL] [Abstract][Full Text] [Related]
2. Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through.
Brumm H; Mühlhaus J; Bolze F; Scherag S; Hinney A; Hebebrand J; Wiegand S; Klingenspor M; Grüters A; Krude H; Biebermann H
Obesity (Silver Spring); 2012 May; 20(5):1074-81. PubMed ID: 21738238
[TBL] [Abstract][Full Text] [Related]
3. A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays.
McElroy SP; Nomura T; Torrie LS; Warbrick E; Gartner U; Wood G; McLean WH
PLoS Biol; 2013; 11(6):e1001593. PubMed ID: 23824517
[TBL] [Abstract][Full Text] [Related]
4. Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.
Nagel-Wolfrum K; Möller F; Penner I; Wolfrum U
Vis Neurosci; 2014 Sep; 31(4-5):309-16. PubMed ID: 24912600
[TBL] [Abstract][Full Text] [Related]
5. Use of PTC124 for nonsense suppression therapy targeting BMP4 nonsense variants in vitro and the bmp4st72 allele in zebrafish.
Krall M; Htun S; Slavotinek A
PLoS One; 2019; 14(4):e0212121. PubMed ID: 31017898
[TBL] [Abstract][Full Text] [Related]
6. In vitro read-through of phenylalanine hydroxylase (PAH) nonsense mutations using aminoglycosides: a potential therapy for phenylketonuria.
Ho G; Reichardt J; Christodoulou J
J Inherit Metab Dis; 2013 Nov; 36(6):955-9. PubMed ID: 23532445
[TBL] [Abstract][Full Text] [Related]
7. Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome.
Yu H; Liu X; Huang J; Zhang Y; Hu R; Pu J
Int J Mol Med; 2014 Mar; 33(3):729-35. PubMed ID: 24366185
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation.
Goldmann T; Overlack N; Möller F; Belakhov V; van Wyk M; Baasov T; Wolfrum U; Nagel-Wolfrum K
EMBO Mol Med; 2012 Nov; 4(11):1186-99. PubMed ID: 23027640
[TBL] [Abstract][Full Text] [Related]
9. Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms.
Ng MY; Li H; Ghelfi MD; Goldman YE; Cooperman BS
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33414181
[TBL] [Abstract][Full Text] [Related]
10. Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124).
Finkel RS
J Child Neurol; 2010 Sep; 25(9):1158-64. PubMed ID: 20519671
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression.
Auld DS; Thorne N; Maguire WF; Inglese J
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3585-90. PubMed ID: 19208811
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycoside drugs induce efficient read-through of
Fazzari M; Frasca A; Bifari F; Landsberger N
RNA Biol; 2019 Oct; 16(10):1414-1423. PubMed ID: 31232219
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
14. Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model.
Moosajee M; Tracey-White D; Smart M; Weetall M; Torriano S; Kalatzis V; da Cruz L; Coffey P; Webster AR; Welch E
Hum Mol Genet; 2016 Aug; 25(16):3416-3431. PubMed ID: 27329764
[TBL] [Abstract][Full Text] [Related]
15. Ataluren for the Treatment of Usher Syndrome 2A Caused by Nonsense Mutations.
Samanta A; Stingl K; Kohl S; Ries J; Linnert J; Nagel-Wolfrum K
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842393
[TBL] [Abstract][Full Text] [Related]
16. Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening.
Pibiri I; Lentini L; Tutone M; Melfi R; Pace A; Di Leonardo A
Eur J Med Chem; 2016 Oct; 122():429-435. PubMed ID: 27404557
[TBL] [Abstract][Full Text] [Related]
17. Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations.
Dranchak PK; Di Pietro E; Snowden A; Oesch N; Braverman NE; Steinberg SJ; Hacia JG
J Cell Biochem; 2011 May; 112(5):1250-8. PubMed ID: 21465523
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the melanocortin-4-receptor nonsense mutation W16X in vitro and in vivo.
Bolze F; Rink N; Brumm H; Kühn R; Mocek S; Schwarz AE; Kless C; Biebermann H; Wurst W; Rozman J; Klingenspor M
Pharmacogenomics J; 2013 Feb; 13(1):80-93. PubMed ID: 21969101
[TBL] [Abstract][Full Text] [Related]
19. PTC124 targets genetic disorders caused by nonsense mutations.
Welch EM; Barton ER; Zhuo J; Tomizawa Y; Friesen WJ; Trifillis P; Paushkin S; Patel M; Trotta CR; Hwang S; Wilde RG; Karp G; Takasugi J; Chen G; Jones S; Ren H; Moon YC; Corson D; Turpoff AA; Campbell JA; Conn MM; Khan A; Almstead NG; Hedrick J; Mollin A; Risher N; Weetall M; Yeh S; Branstrom AA; Colacino JM; Babiak J; Ju WD; Hirawat S; Northcutt VJ; Miller LL; Spatrick P; He F; Kawana M; Feng H; Jacobson A; Peltz SW; Sweeney HL
Nature; 2007 May; 447(7140):87-91. PubMed ID: 17450125
[TBL] [Abstract][Full Text] [Related]
20. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
Keeling KM; Bedwell DM
J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
